2022 Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines

2024 Clinical practice guidelines for Stable coronary artery disease

ACE inhibitor lisinopril in cardiac patients: results of evidence-based trials

ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC

Adherence to Attendance at Outpatient Clinic and Longterm Survival of Patients after Stroke in Outpatient Setting: the Data of REGION-M Registry

Adherence to attendance at outpatient clinic, quality of prehospital therapy, and direct outcome of acute coronary syndrome: analysis within LIS-3 registry

Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study)

Adherence to therapy and the risk of cardiovascular events in patients with heart failure: data from the outpatient registry

Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study)

Adherence to Visits to Medical Institutions and Quality of Therapy after Acute Coronary Syndrome (according to the LIS Registry 3)

ADVERSE EVENT OF DRUG THERAPY (THE FIRST RESULTS OF THE STUDY ACCORDING TO THE PROFILE OUTPATIENT REGISTER)

ADVERSE PROGNOSTIC FACTORS FOR THE CATHETER ISOLATION OF PULMONARY VEINS OSTIA EFFICACY IN PAROXYSMAL ATRIAL FIBRILLATION WITH NO ORGANIC HEART PATHOLOGY (THE PRUF STUDY)

Algorithm of appointment (examination; consultation) of patients under follow-up care by a general practitioner

THE ANALYSIS OF FACTORS INFLUENCING THE TERMS OF HOSPITAL ADMISSION IN PATIENTS WITH ACUTE CORONARY SYNDROM (ACCORDING TO THE LIS STUDY DATA – LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION)

Analysis of questionnaires from the perspective of hospitalization risk prediction. Systematic review

ANALYSIS OF THE PRACTICE OF COMBINATIONAL ANTIHYPERTENSION THERAPY BY THE DATA FROM TWO OUTPATIENT REGISTRIES

Analysis of the problem of low adherence of patients to attendance at outpatient clinics and cardiorehabilitation programs according to the data from published studies

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY

Angiotensin Converting Enzyme Inhibitors and the Risk of Lung Cancer – New Scientific Evidences or Another Example of “Pseudo-Evidence” Medicine?